{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:19:20Z","timestamp":1791674360893,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.ygyno.2008.10.012","type":"journal-article","created":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T13:14:44Z","timestamp":1228310084000},"page":"293-299","source":"Crossref","is-referenced-by-count":227,"title":["Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science"],"prefix":"10.1016","volume":"112","author":[{"given":"Nicolas","family":"Wentzensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9590","key":"10.1016\/j.ygyno.2008.10.012_bib1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"S1","key":"10.1016\/j.ygyno.2008.10.012_bib2","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2007.11.069","article-title":"Cervical cancer screening following prophylactic human papillomavirus vaccination","volume":"26","author":"Franco","year":"2008","journal-title":"Vaccine"},{"issue":"9601","key":"10.1016\/j.ygyno.2008.10.012_bib3","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ygyno.2008.10.012_bib4","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ygyno.2008.10.012_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.10.012_bib6","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans 2005: Lyon F. Human Papillomaviruses. IARC Monographs ed. 2007."},{"issue":"4","key":"10.1016\/j.ygyno.2008.10.012_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis. Markers"},{"issue":"11","key":"10.1016\/j.ygyno.2008.10.012_bib8","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ygyno.2008.10.012_bib9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ygyno.2008.10.012_bib10","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1158\/1078-0432.CCR-03-0143","article-title":"Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors","volume":"10","author":"Widschwendter","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ygyno.2004.03.013","article-title":"Epigenetic and genetic alternation of PTEN in cervical neoplasm","volume":"93","author":"Cheung","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2008.10.012_bib12","first-page":"2981","article-title":"The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix","volume":"9","author":"Cohen","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ygyno.2007.01.045","article-title":"Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma","volume":"105","author":"Kang","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.10.012_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2004.08.050","article-title":"IGSF4 promoter methylation and expression silencing in human cervical cancer","volume":"96","author":"Li","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.10.012_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00439-007-0375-6","article-title":"Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene","volume":"122","author":"Singh","year":"2007","journal-title":"Hum. Genet."},{"issue":"4","key":"10.1016\/j.ygyno.2008.10.012_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jnci\/djh031","article-title":"TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia","volume":"96","author":"Steenbergen","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2008.10.012_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ijc.11051","article-title":"Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers","volume":"105","author":"Yu","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"39","key":"10.1016\/j.ygyno.2008.10.012_bib18","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1038\/sj.onc.1209530","article-title":"Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer","volume":"25","author":"Zhang","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ygyno.2008.10.012_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jnci\/dji041","article-title":"Detection of hypermethylated genes in women with and without cervical neoplasia","volume":"97","author":"Feng","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"16","key":"10.1016\/j.ygyno.2008.10.012_bib20","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.ejca.2008.07.014","article-title":"Wentzensen N. p16 methylation does not affect protein expression in cervical carcinogenesis","author":"Nehls","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2008.10.012_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.23519","article-title":"Identification of novel DNA methylation markers in cervical cancer","volume":"123","author":"Lai","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2008.10.012_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/1055-9965.EPI-05-0323","article-title":"Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis","volume":"15","author":"Sova","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.ygyno.2008.10.012_bib23","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1158\/0008-5472.CAN-07-3194","article-title":"Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.10.012_bib24","article-title":"Epigenomic profiling of cancer cells","author":"Gargiulo","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.10.012_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cncr.23258","article-title":"Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests","volume":"114","author":"Kahn","year":"2008","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2008.10.012_bib26","first-page":"1888","article-title":"Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection","volume":"63","author":"Kuzmin","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ygyno.2008.10.012_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2007.03.015","article-title":"Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer","volume":"255","author":"Choi","year":"2007","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.ygyno.2008.10.012_bib28","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1158\/1055-9965.EPI-06-0694","article-title":"Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia","volume":"16","author":"Feng","year":"2007","journal-title":"Cancer Epidemiol., Biomarkers Prev."},{"issue":"10","key":"10.1016\/j.ygyno.2008.10.012_bib29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604055","article-title":"Sequential gene promoter methylation during HPV-induced cervical carcinogenesis","volume":"97","author":"Henken","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1447-0756.2007.00517.x","article-title":"Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer","volume":"33","author":"Jo","year":"2007","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ygyno.2006.10.003","article-title":"Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias","volume":"104","author":"Lai","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2008.10.012_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00404-007-0511-5","article-title":"Evaluation of DAPK gene methylation and HPV and EBV infection in cervical cells from patients with normal cytology and colposcopy","author":"Lattario","year":"2008","journal-title":"Arch. Gynecol. Obstet."},{"issue":"7","key":"10.1016\/j.ygyno.2008.10.012_bib33","first-page":"881","article-title":"DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions","volume":"232","author":"Oikonomou","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"issue":"6","key":"10.1016\/j.ygyno.2008.10.012_bib34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.onc.1209839","article-title":"The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation","volume":"26","author":"Seng","year":"2007","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2007.08.057","article-title":"Evaluation of candidate methylation markers to detect cervical neoplasia","volume":"107","author":"Shivapurkar","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib36","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1525-1438.2006.00522.x","article-title":"Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics","volume":"16","author":"Jeong","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2008.10.012_bib37","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/ijc.21609","article-title":"Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma","volume":"118","author":"Kang","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.10.012_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2407-6-55","article-title":"Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer","volume":"6","author":"Kitkumthorn","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2008.10.012_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-4598-5-16","article-title":"Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression","volume":"5","author":"Narayan","year":"2006","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2008.10.012_bib40","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/j.1525-1438.2006.00669.x","article-title":"Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients","volume":"16","author":"Ren","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2008.10.012_bib41","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/ijc.22060","article-title":"Assessment of gene promoter hypermethylation for detection of cervical neoplasia","volume":"119","author":"Wisman","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2008.10.012_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2004.09.031","article-title":"Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer","volume":"96","author":"Kang","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2008.10.012_bib43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ijc.20622","article-title":"Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies","volume":"113","author":"Shigematsu","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2008.10.012_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ijc.20910","article-title":"Aberrant methylation of Reprimo in human malignancies","volume":"115","author":"Takahashi","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2008.10.012_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cncr.20425","article-title":"DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis","volume":"102","author":"Gustafson","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2008.10.012_bib46","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ijc.11652","article-title":"Frequent hypermethylation of 5\u2032 flanking region of TIMP-2 gene in cervical cancer","volume":"108","author":"Ivanova","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2008.10.012_bib47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/labinvest.3700060","article-title":"Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma","volume":"84","author":"Kim","year":"2004","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib48","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajog.2003.09.036","article-title":"Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis","volume":"190","author":"Lea","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.ygyno.2008.10.012_bib49","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1158\/0008-5472.CAN-04-0245","article-title":"Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer","volume":"64","author":"Narayan","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ygyno.2008.10.012_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1541-7786.289.2.5","article-title":"Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study","volume":"2","author":"Reesink-Peters","year":"2004","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2008.10.012_bib51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ijc.20041","article-title":"Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types","volume":"109","author":"Shivapurkar","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2008.10.012_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2004.01.036","article-title":"Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer","volume":"93","author":"Widschwendter","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.10.012_bib53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1158\/1078-0432.CCR-0825-03","article-title":"DNA methylation in serum and tumors of cervical cancer patients","volume":"10","author":"Widschwendter","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2008.10.012_bib54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ygyno.2004.01.039","article-title":"Detection of hypermethylated genes in tumor and plasma of cervical cancer patients","volume":"93","author":"Yang","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib55","first-page":"599","article-title":"Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers","volume":"23","author":"Chan","year":"2003","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2008.10.012_bib56","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0959-8049(02)00175-2","article-title":"E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours","volume":"39","author":"Chen","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.10.012_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-2-24","article-title":"Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome","volume":"2","author":"Narayan","year":"2003","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2008.10.012_bib58","first-page":"417","article-title":"5\u2032-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas","volume":"27","author":"Wu","year":"2003","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.ygyno.2008.10.012_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2407-2-4","article-title":"Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer","volume":"2","author":"Ivanova","year":"2002","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2008.10.012_bib60","first-page":"1982","article-title":"Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix","volume":"7","author":"Dong","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2008.10.012_bib61","first-page":"584","article-title":"Aberrant methylation during cervical carcinogenesis","volume":"7","author":"Virmani","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2008.10.012_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3835(98)00327-9","article-title":"Methylation of p16INK4A in primary gynecologic malignancy","volume":"136","author":"Wong","year":"1999","journal-title":"Cancer Lett."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808008822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808008822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T21:52:17Z","timestamp":1684705937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808008822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0090825808008822"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.10.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}